Strides Pharma Science Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
1,070.49
1,046.42
1,035.28
938.64
1,013.49
Other Income Qtr Cr-13.558.7535.858.6527.12
Operating Revenues Qtr1,084.041,037.67999.43929.99986.37

*All values are in Cr.

Operating Expenses Qtr
854.30
843.86
846.30
763.40
830.81
Operating Profit Qtr
229.73
193.81
153.13
166.59
155.56
EBIDT Qtr Cr
208.19
246.65
24.05
169.26
175.34
Depreciation Qtr
49.76
51.23
60.11
59.59
60.93
Net Profit Qtr
18.18
49.67
-131.34
-7.11
-9.54
Basic EPS Qtr
1.98
5.43
-14.54
-0.79
-1.06
Open Demat Account
or Resume your Application
+91 -

personImage